BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

501 related articles for article (PubMed ID: 32037619)

  • 21. Overexpression of circular RNA circ_001569 indicates poor prognosis in hepatocellular carcinoma and promotes cell growth and metastasis by sponging miR-411-5p and miR-432-5p.
    Liu H; Xue L; Song C; Liu F; Jiang T; Yang X
    Biochem Biophys Res Commun; 2018 Sep; 503(4):2659-2665. PubMed ID: 30086881
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Overexpression of circ_0021093 circular RNA forecasts an unfavorable prognosis and facilitates cell progression by targeting the miR-766-3p/MTA3 pathway in hepatocellular carcinoma.
    Liu L; Qi X; Gui Y; Huo H; Yang X; Yang L
    Gene; 2019 Sep; 714():143992. PubMed ID: 31330234
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Silencing of hsa_circ_0101145 reverses the epithelial-mesenchymal transition in hepatocellular carcinoma via regulation of the miR-548c-3p/LAMC2 axis.
    Jin J; Liu H; Jin M; Li W; Xu H; Wei F
    Aging (Albany NY); 2020 Jun; 12(12):11623-11635. PubMed ID: 32554866
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Circular RNA circ-FOXP1 induced by SOX9 promotes hepatocellular carcinoma progression via sponging miR-875-3p and miR-421.
    Wang W; Li Y; Li X; Liu B; Han S; Li X; Zhang B; Li J; Sun S
    Biomed Pharmacother; 2020 Jan; 121():109517. PubMed ID: 31698267
    [TBL] [Abstract][Full Text] [Related]  

  • 25. circRNA hsa_circ_104566 Sponged miR-338-3p to Promote Hepatocellular Carcinoma Progression.
    Liu G; Guo W; Rao M; Qin J; Hu F; Li K
    Cell Transplant; 2020; 29():963689720963948. PubMed ID: 33028110
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Circular RNA circMET drives immunosuppression and anti-PD1 therapy resistance in hepatocellular carcinoma via the miR-30-5p/snail/DPP4 axis.
    Huang XY; Zhang PF; Wei CY; Peng R; Lu JC; Gao C; Cai JB; Yang X; Fan J; Ke AW; Zhou J; Shi GM
    Mol Cancer; 2020 May; 19(1):92. PubMed ID: 32430013
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Circular RNA circ_0020710 drives tumor progression and immune evasion by regulating the miR-370-3p/CXCL12 axis in melanoma.
    Wei CY; Zhu MX; Lu NH; Liu JQ; Yang YW; Zhang Y; Shi YD; Feng ZH; Li JX; Qi FZ; Gu JY
    Mol Cancer; 2020 May; 19(1):84. PubMed ID: 32381016
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hsa_circ_0079875 functions as a competitive endogenous RNA to promote hepatocellular carcinoma progression.
    Liu Y; Luo X; Chen W; Dong Z; Cheng T; Chen L; Ju L; Cai W; Bian Z
    Cell Cycle; 2024 Mar; 23(5):519-536. PubMed ID: 38684479
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Circular RNA circ_0074027 indicates a poor prognosis for NSCLC patients and modulates cell proliferation, apoptosis, and invasion via miR-185-3p mediated BRD4/MADD activation.
    Gao P; Wang Z; Hu Z; Jiao X; Yao Y
    J Cell Biochem; 2020 Mar; 121(3):2632-2642. PubMed ID: 31680319
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Circ-PRMT5 enhances the proliferation, migration and glycolysis of hepatoma cells by targeting miR-188-5p/HK2 axis.
    Ding Z; Guo L; Deng Z; Li P
    Ann Hepatol; 2020; 19(3):269-279. PubMed ID: 32089501
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CircRNA hsa_circ_0110102 inhibited macrophage activation and hepatocellular carcinoma progression via miR-580-5p/PPARĪ±/CCL2 pathway.
    Wang X; Sheng W; Xu T; Xu J; Gao R; Zhang Z
    Aging (Albany NY); 2021 Apr; 13(8):11969-11987. PubMed ID: 33891564
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Piplartine attenuates the proliferation of hepatocellular carcinoma cells via regulating hsa_circ_100338 expression.
    Cheng X; Tian P; Zheng W; Yan X
    Cancer Med; 2020 Jun; 9(12):4265-4273. PubMed ID: 32281302
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CircCAMSAP1 promotes hepatocellular carcinoma progression through miR-1294/GRAMD1A pathway.
    Luo Z; Lu L; Tang Q; Wei W; Chen P; Chen Y; Pu J; Wang J
    J Cell Mol Med; 2021 Apr; 25(8):3793-3802. PubMed ID: 33484498
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Circular RNA-ABCB10 suppresses hepatocellular carcinoma progression through upregulating NRP1/ABL2 via sponging miR-340-5p/miR-452-5p.
    Yang W; Ju HY; Tian XF
    Eur Rev Med Pharmacol Sci; 2020 Mar; 24(5):2347-2357. PubMed ID: 32196586
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Circ_0046600 promotes hepatocellular carcinoma progression via up-regulating SERBP1 through sequestering miR-1258.
    Zhang D; Zhang Y; Zhang X; Zhai H; Sun X; Li Y
    Pathol Res Pract; 2021 Dec; 228():153681. PubMed ID: 34784519
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Circular RNA circ_0074026 indicates unfavorable prognosis for patients with glioma and facilitates oncogenesis of tumor cells by targeting miR-1304 to modulate ERBB4 expression.
    Chen M; Liu X; Xie P; Wang P; Liu M; Zhan Y; Wang H; Feng Y; Li Y
    J Cell Physiol; 2020 May; 235(5):4688-4697. PubMed ID: 31643077
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Circular RNA circ_0007142 regulates cell proliferation, apoptosis, migration and invasion via miR-455-5p/SGK1 axis in colorectal cancer.
    Wen T; Wu H; Zhang L; Li K; Xiao X; Zhang L; Zhang Y
    Anticancer Drugs; 2021 Jan; 32(1):22-33. PubMed ID: 32889894
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hsa_circ_0008092 Contributes to Cell Proliferation and Metastasis in Hepatocellular Carcinoma via the miR-502-5p/CCND1 Axis.
    Maimaiti Y; Kamali A; Yang P; Zhong K; Abuduhadeer X
    Protein Pept Lett; 2022; 29(7):595-604. PubMed ID: 35899951
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Circ_0009910 promotes proliferation and metastasis of hepatocellular carcinoma cells through miR-335-5p/ROCK1 axis.
    Li HW; Liu J
    Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):1725-1735. PubMed ID: 32141540
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CircRNA circ-0038718 promotes hepatocellular carcinoma progression through sponging miR-139-3p.
    Sun R; Li H; Li J; Shen S; Cui G; Dong G
    Biochem Biophys Res Commun; 2020 Dec; 533(4):845-852. PubMed ID: 33008587
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.